Category Archives: Advisory Committee Prepapartion

FDA AdComm Calendar for 2011 – Where is the Action?

At nearly the end of 2010, the FDA published the tentative calendar for advisory committee meetings for 2011.  Naturally, the agency cannot precisely detail the calendar at this stage, but it does provide a bit of a signal regardomg the … Continue reading

Posted in Advisory Committee Prepapartion, Uncategorized | 3 Comments

Guidance on Comments – Advisory Committee Prep on Open Public Comment Period

As noted in the Weekly Roundup on Friday, last week the FDA published a Final Guidance on the Open Public Comment period at FDA Advisory Committee meetings.  On a side note, it is perhaps worth noting that this updated the … Continue reading

Posted in Advisory Committee Prepapartion, FDA Policy | 1 Comment

Communications and Marketing Implications of a Change in FDA Policy for Medical Device AdComms

In June of 2008, January of 2009 and again in June 2009 the General Accounting Office issued reports on the FDA and its oversight of medical devices.  The June 2009 report echoed findings from the earlier January report, put forth a recommendation … Continue reading

Posted in Advisory Committee Prepapartion, FDA Policy | Comments Off

How Social Media Could Improve FDA AdComm Meetings, Part 1

i-Pad, therefore i-Am.   A colleague asked me the other day – what is so special about the i-Pad that you don't already get on your phone or your laptop?   I responded by saying that right now, in computing, … Continue reading

Posted in Advisory Committee Prepapartion, FDA Policy, New and Social Media | 1 Comment

Begin Communications Earlier in the Drug Review Process

One of the many lessons available from the track record of the FDA last year involves communications and preparation for advisory committee and FDA approvals.  There increasing numbers of approvable letters than there were declines in approvals last year.  There … Continue reading

Posted in Advisory Committee Prepapartion | Comments Off